http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3517133-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95363fc2cf0b49e7a4aef32d7cb692a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_963646cbea69a29603bb2777864e3275
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-01001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
filingDate 2017-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b938e0bd2866d960a12638be711b49b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43a87674c7e699753023a586ab9e6a4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d64f2881229110a6cbb0edc480e2287c
publicationDate 2019-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3517133-A2
titleOfInvention Pharmaceutical composition containing mtor inhibitor for treating macular degeneration
abstract The present invention relates to a pharmaceutical composition for treating macular degeneration, and more particularly to a pharmaceutical composition for treating macular degeneration, which comprises an inhibitor of mTOR gene expression. The pharmaceutical composition according to the present invention can effectively treat age-related macular degeneration, a representative retinal disease that causes blindness in adults.
priorityDate 2016-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226486686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45157623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396654
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405859
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID252023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226487577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4752
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13838821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID493591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9885981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID228404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15867527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829

Total number of triples: 84.